Feature

Jeffrey Weber, MD, PhD, Giant of Cancer Care, Dies


 

Jeffrey S. Weber, MD, PhD, the 2016 winner of the Giants of Cancer Care award in melanoma and a valued contributor to Medscape Oncology, has died.

Dr. Weber, a melanoma and cancer immunotherapy specialist, served as deputy director of the Laura and Isaac Perlmutter Cancer Center at New York University (NYU) Langone Medical Center in New York City. He also held positions as the Laura and Isaac Perlmutter Professor of Oncology in the Department of Medicine at the NYU Grossman School of Medicine, director of the Experimental Therapeutics Program, and co-leader of the Clinical Melanoma Program Board at NYU Langone Health.

Dr. Weber was a principal investigator on many studies, including pivotal clinical drug trials in melanoma and trials focused on managing autoimmune side effects from immunotherapy. He published more than 150 articles in top peer-reviewed journals.

For many years, Dr. Weber hosted the popular “Weber on Oncology” series of video contributions for Medscape Oncology, sharing updates and insights on noteworthy research and breakthroughs in melanoma.

“The Melanoma Research Alliance mourns the passing of Dr. Jeffrey S. Weber, a true pioneer in the field of cancer immunotherapy and an extraordinary leader in melanoma research. His contributions have forever changed the landscape of melanoma treatment, bringing groundbreaking advances from the lab into clinical practice and offering hope to countless patients,” the Melanoma Research Alliance posted on LinkedIn.

Many X users also shared condolences and memories of Dr. Weber, praising his numerous contributions and accomplishments.

“[Cancer Research Institute] mourns the loss of Dr. Jeffrey S. Weber ... [a]s an accomplished physician scientist, Dr. Weber drove advances in melanoma research, and played an active role in educating patients about the lifesaving power of immunotherapy,” the Cancer Research Institute posted.

A colleague noted that “[h]e was involved in the early days of cytokine and cell therapy and most recently led studies of personalized vaccines for melanoma patients. ... He was a great friend and colleague to many of us in the melanoma and immunotherapy field and we will remember him as a pioneer, thought leader and compassionate physician.”

A version of this article first appeared on Medscape.com.

Recommended Reading

Psychiatric, Autoimmune Comorbidities Increased in Patients with Alopecia Areata
MDedge Dermatology
Case Series: Upadacitinib Effective for Granulomatous Cheilitis
MDedge Dermatology
Can Addressing Depression Reduce Chemo Toxicity in Older Adults?
MDedge Dermatology
Immunotherapy May Be Overused in Dying Patients With Cancer
MDedge Dermatology
Vulvar Inflammatory Dermatoses: New Approaches for Diagnosis and Treatment
MDedge Dermatology
Distinguishing Generalized Bullous Fixed Drug Eruption From SJS/TEN: A Retrospective Study on Clinical and Demographic Features
MDedge Dermatology
Erythema Nodosum Triggered by a Bite From a Copperhead Snake
MDedge Dermatology
Association Between Pruritus and Fibromyalgia: Results of a Population-Based, Cross-Sectional Study
MDedge Dermatology
Study Identifies Oral Antibiotics Linked to Severe Cutaneous Reactions
MDedge Dermatology
Applications for the CUTIS 2025 Resident Corner Column
MDedge Dermatology